We report the use of dexmedetomidine infusion in critically ill infants and children at doses of 0.2–0.7 μg/kg/hr for a median duration of 141 hours. The major findings from our study include 1) ...
NEW HAVEN, Conn., Nov. 06, 2023 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in ...
Medetomidine, a veterinary sedative, mixed into fentanyl has sent thousands to hospitals, not only for overdose but for life-threatening withdrawal. It is spreading to other cities.
WOODCLIFF LAKE, N.J., Sept. 8, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has resumed shipping dexmedetomidine hydrochloride (HCl) injection, EQ 100 mcg base/mL, ...
LAKE FOREST, Ill., Oct. 30 /PRNewswire-FirstCall/ -- Hospira, Inc. , a global specialty pharmaceutical and medication delivery company, announced today that the U.S ...
Patients who received dexmedetomidine for greater than or equal to 72 hours numbered 114. After excluding 16 patients (14 had dexmedetomidine paused during the 72 hours, and two patients for whom we ...
LAKE FOREST, Ill., Oct. 30 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE:HSP), a global specialty pharmaceutical and medication delivery company, announced today that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback